SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001588209-13-000002
Filing Date
2013-10-04
Accepted
2013-10-04 15:51:18
Documents
1
Period of Report
2013-09-16

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 3  
1 PRIMARY DOCUMENT primary_doc.xml 3 1430
  Complete submission text file 0001588209-13-000002.txt   2977
Mailing Address 16640 CHESTERFIELD GROVE ROAD SUITE 200 CHESTERFIELD MO 63005
Business Address 16640 CHESTERFIELD GROVE ROAD SUITE 200 CHESTERFIELD MO 63005 3146456600
K-V Pharmaceutical Co (Issuer) CIK: 0000057055 (see all company filings)

IRS No.: 430618919 | State of Incorp.: DE | Fiscal Year End: 0331
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O KINGDON CAPITAL MANAGEMENT, L.L.C. 152 WEST 57TH STREET, 50TH FLOOR NEW YORK NY 10019
Business Address
Siegel Jonathan B. (Reporting) CIK: 0001588209 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-09601 | Film No.: 131136696